Jiahao Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiahao Zhou has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Xiaomin Ying
Center for Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, China
6 shared publications - Zhen He
Center for Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, China
6 shared publications - Jing Wang
Center for Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, China
5 shared publications - Jinhui Shi
Center for Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, China
5 shared publications - Tongtong Kan
Center for Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, China
4 shared publications Guohua Dong
Center for Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, China
3 shared publications
Latest Publications
- Open Access
- 26 August 2026
- Published by Springer Nature in Nature Computational Science
- Vol. 6 (9) , 1039
Publisher Correction: Continual integration of single-cell multimodal data with MIRACLE
- 26 August 2026
- Published by Springer Nature in Nature Computational Science
- Vol. 6 (9) , 1039
Open AccessPublisher Correction: Continual integration of single-cell multimodal data with MIRACLE
- Open Access
- 31 July 2026
- Published by Springer Nature in Nature Computational Science
- Vol. 6 (9) , 988-1004
Continual integration of single-cell multimodal data with MIRACLE
Single-cell sequencing has transformed our understanding of cellular heterogeneity, enabling the construction of multi-omics atlases through data integration. However, conventional atlas updates require full reintegration of all datasets, creating scalability challenges that limit the timeliness and adaptability of biomedical research. Here we present multimodal integration with continual learning (MIRACLE), an online learning framework for scalable multimodal integration. Using dynamic architecture adaptation and data rehearsal, MIRACLE continually integrates diverse datasets while preserving biological fidelity. Across evaluations, MIRACLE achieves accurate online integration with substantially improved efficiency, refining and expanding atlases with new cross-modal, cross-tissue and cross-disease data. Applied to respiratory infections, it reveals both shared and pathogen-specific immune mechanisms in coronavirus disease 2019, influenza A and tuberculosis. Overall, MIRACLE provides an efficient and collaborative solution for the continual integration, sharing and exploration of biological knowledge.
- 31 July 2026
- Published by Springer Nature in Nature Computational Science
- Vol. 6 (9) , 988-1004
Open AccessContinual integration of single-cell multimodal data with MIRACLE
Single-cell sequencing has transformed our understanding of cellular heterogeneity, enabling the construction of multi-omics atlases through data integration. However, conventional atlas updates require full reintegration of all datasets, creating scalability challenges that limit the timeliness and adaptability of biomedical research. Here we present multimodal integration with continual learning (MIRACLE), an online learning framework for scalable multimodal integration. Using dynamic architecture adaptation and data rehearsal, MIRACLE continually integrates diverse datasets while preserving biological fidelity. Across evaluations, MIRACLE achieves accurate online integration with substantially improved efficiency, refining and expanding atlases with new cross-modal, cross-tissue and cross-disease data. Applied to respiratory infections, it reveals both shared and pathogen-specific immune mechanisms in coronavirus disease 2019, influenza A and tuberculosis. Overall, MIRACLE provides an efficient and collaborative solution for the continual integration, sharing and exploration of biological knowledge.
- 8 July 2026
- Published by Bentham Science Publishers Ltd. in Current Cancer Drug Targets
- Vol. 26, 1-20
Shared Genetic Architecture of Epilepsy and Glioma Revealed by Mendelian Randomization: Identifying Prognostic Biomarkers and Therapeutic Targets
Background: Glioma-Related Epilepsy (GRE) is a hallmark comorbidity of Low-Grade Glioma (LGG), yet the cellular and molecular mechanisms through which germline epilepsy susceptibility converges with tumor biology to shape clinical outcomes remain poorly understood. Methods: Genome-Wide Association Studies (GWAS), expression quantitative trait loci (eQTL) data, single-cell RNA sequencing, and spatial transcriptomics were integrated. Causal inference, phenotype-driven single-cell analyses, and machine learning were applied to identify genetically informed cellular mechanisms underlying GRE. Results: A total of 68 germline loci shared by glioma and epilepsy (FDRIVW < 0.05) were integrated, with microglia and excitatory neurons as the principal mediating cell types. Four seizure-associated genes (WFIKKN1, WDSUB1, SPARCL1, and CALD1) were subsequently identified in TCGA-LGG, with high-confidence enhancer-promoter support for three of them (colco.PP4 > 0.9). A four-gene signature consistently stratified overall survival across three independent cohorts (TCGA-LGG, CGGA_325, and GSE16011) and correlated with immune checkpoint gene expression. High-risk patients showed higher sensitivity to cyclopamine, according to in silico drug response. Discussion: These findings support a neuroimmune model in which pleiotropic germline variants act via microglia and excitatory neurons to link seizure biology with tumor immunity and prognosis. At the same time, in silico therapeutic predictions require functional and multi-ancestry validation. Conclusion: These results reveal a common genetic architecture between glioma and epilepsy, offering candidate biomarkers and therapeutic strategies for the management of GRE.
- 8 July 2026
- Published by Bentham Science Publishers Ltd. in Current Cancer Drug Targets
- Vol. 26, 1-20
Shared Genetic Architecture of Epilepsy and Glioma Revealed by Mendelian Randomization: Identifying Prognostic Biomarkers and Therapeutic Targets
Background: Glioma-Related Epilepsy (GRE) is a hallmark comorbidity of Low-Grade Glioma (LGG), yet the cellular and molecular mechanisms through which germline epilepsy susceptibility converges with tumor biology to shape clinical outcomes remain poorly understood. Methods: Genome-Wide Association Studies (GWAS), expression quantitative trait loci (eQTL) data, single-cell RNA sequencing, and spatial transcriptomics were integrated. Causal inference, phenotype-driven single-cell analyses, and machine learning were applied to identify genetically informed cellular mechanisms underlying GRE. Results: A total of 68 germline loci shared by glioma and epilepsy (FDRIVW < 0.05) were integrated, with microglia and excitatory neurons as the principal mediating cell types. Four seizure-associated genes (WFIKKN1, WDSUB1, SPARCL1, and CALD1) were subsequently identified in TCGA-LGG, with high-confidence enhancer-promoter support for three of them (colco.PP4 > 0.9). A four-gene signature consistently stratified overall survival across three independent cohorts (TCGA-LGG, CGGA_325, and GSE16011) and correlated with immune checkpoint gene expression. High-risk patients showed higher sensitivity to cyclopamine, according to in silico drug response. Discussion: These findings support a neuroimmune model in which pleiotropic germline variants act via microglia and excitatory neurons to link seizure biology with tumor immunity and prognosis. At the same time, in silico therapeutic predictions require functional and multi-ancestry validation. Conclusion: These results reveal a common genetic architecture between glioma and epilepsy, offering candidate biomarkers and therapeutic strategies for the management of GRE.
- Open Access
- 7 January 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Generalizable Single-cell Multimodal Data Integration with Self-supervised Learning
Recent breakthroughs in single-cell multi-omics technologies have enabled simultaneous measurement of diverse cellular modalities, offering unprecedented biological insights. However, integrating such multimodal data faces dual challenges: Small-scale paired-modality studies (hundreds of cells) risk overfitting, while large-scale reference atlases often struggle to generalize effectively to new datasets. To overcome these challenges, we present multimodal integration with self-supervised learning (MINERVA), a unified deep learning framework employing self-supervised strategies for single-cell multimodal integration. MINERVA outperforms six state-of-the-art methods in dimensionality reduction, missing feature imputation, and batch effect correction, even with limited training cells. For large-scale applications, MINERVA constructs scalable multi-tissue references that support zero-shot knowledge transfer to unseen datasets, instant cell type annotation, novel cell states identification, and comprehensive downstream analyses, all without model retraining. Uniquely bridging small-scale precision with atlas-level generalization, MINERVA serves as a versatile tool for both de novo integration and cost-effective atlas reuse in single-cell research.
- 7 January 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Open AccessGeneralizable Single-cell Multimodal Data Integration with Self-supervised Learning
Recent breakthroughs in single-cell multi-omics technologies have enabled simultaneous measurement of diverse cellular modalities, offering unprecedented biological insights. However, integrating such multimodal data faces dual challenges: Small-scale paired-modality studies (hundreds of cells) risk overfitting, while large-scale reference atlases often struggle to generalize effectively to new datasets. To overcome these challenges, we present multimodal integration with self-supervised learning (MINERVA), a unified deep learning framework employing self-supervised strategies for single-cell multimodal integration. MINERVA outperforms six state-of-the-art methods in dimensionality reduction, missing feature imputation, and batch effect correction, even with limited training cells. For large-scale applications, MINERVA constructs scalable multi-tissue references that support zero-shot knowledge transfer to unseen datasets, instant cell type annotation, novel cell states identification, and comprehensive downstream analyses, all without model retraining. Uniquely bridging small-scale precision with atlas-level generalization, MINERVA serves as a versatile tool for both de novo integration and cost-effective atlas reuse in single-cell research.
- Open Access
- 26 November 2025
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 24 (3)
DBP: Adaptive and Interpretable Factor Analysis for Single-cell RNA-seq Data with Deep Beta Processes
Factor analysis is a method that condenses multiple variables into a few latent factors. It can be used to extract the underlying sources of biological variation in high-dimensional data and distill them into interpretable gene programs. However, existing factorization methods lack adaptability in selecting the optimal number of factors and interpretability in capturing biological variation. To address these concerns, we propose Deep Beta Process (DBP), a deep probabilistic framework for adaptive and interpretable factor analysis of single-cell transcriptomic data. DBP achieves adaptive selection of factors through a stick-breaking Beta process and performs batch correction using an adversarial learning strategy. We validate the flexible factor extraction and robust batch correction capabilities of DBP on simulated datasets. We also demonstrate its superior performance in dimensionality reduction and biological interpretability while explaining biological variation from both cell and gene perspectives using factor and loading matrices. The application of DBP to a gastric adenocarcinoma dataset reveals malignant epithelial cell heterogeneity, providing valuable insights for investigating the molecular mechanisms of disease onset and progression. DBP is available at https://github.com/labomics/DBP and https://ngdc.cncb.ac.cn/biocode/tool/BT007954.
- 26 November 2025
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 24 (3)
Open AccessDBP: Adaptive and Interpretable Factor Analysis for Single-cell RNA-seq Data with Deep Beta Processes
Factor analysis is a method that condenses multiple variables into a few latent factors. It can be used to extract the underlying sources of biological variation in high-dimensional data and distill them into interpretable gene programs. However, existing factorization methods lack adaptability in selecting the optimal number of factors and interpretability in capturing biological variation. To address these concerns, we propose Deep Beta Process (DBP), a deep probabilistic framework for adaptive and interpretable factor analysis of single-cell transcriptomic data. DBP achieves adaptive selection of factors through a stick-breaking Beta process and performs batch correction using an adversarial learning strategy. We validate the flexible factor extraction and robust batch correction capabilities of DBP on simulated datasets. We also demonstrate its superior performance in dimensionality reduction and biological interpretability while explaining biological variation from both cell and gene perspectives using factor and loading matrices. The application of DBP to a gastric adenocarcinoma dataset reveals malignant epithelial cell heterogeneity, providing valuable insights for investigating the molecular mechanisms of disease onset and progression. DBP is available at https://github.com/labomics/DBP and https://ngdc.cncb.ac.cn/biocode/tool/BT007954.
- 5 November 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 30 (5) , 4013-4022
TransGRN: A Transfer Learning-Based Framework for Inferring Gene Regulatory Networks Across Cell Lines
Inferring gene regulatory networks (GRNs) is critical for understanding the mechanisms that govern cellular behavior. Advances in single-cell RNA sequencing (scRNA-seq) have enabled GRN analysis at single-cell resolution and stimulated the development of many computational methods. However, most existing approaches depend heavily on extensive prior regulatory information, which limits their effectiveness in few-shot settings where such data for the target cell type are scarce or unavailable. To address this challenge, we propose TransGRN, a transfer learning-based method for inferring gene regulatory networks (GRNs) across cell lines. TransGRN adopts a cross-cell-line pre-training strategy that combines scRNA-seq data from multiple source cell lines with biological knowledge obtained from large language models. In addition, it includes a regulatory interaction extraction module that integrates gene expression profiles with semantic information. By transferring generalizable gene-gene regulatory patterns from source to target cell lines, TransGRN achieves state-of-the-art performance in both benchmark tests and few-shot GRN inference tasks.
- 5 November 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 30 (5) , 4013-4022
TransGRN: A Transfer Learning-Based Framework for Inferring Gene Regulatory Networks Across Cell Lines
Inferring gene regulatory networks (GRNs) is critical for understanding the mechanisms that govern cellular behavior. Advances in single-cell RNA sequencing (scRNA-seq) have enabled GRN analysis at single-cell resolution and stimulated the development of many computational methods. However, most existing approaches depend heavily on extensive prior regulatory information, which limits their effectiveness in few-shot settings where such data for the target cell type are scarce or unavailable. To address this challenge, we propose TransGRN, a transfer learning-based method for inferring gene regulatory networks (GRNs) across cell lines. TransGRN adopts a cross-cell-line pre-training strategy that combines scRNA-seq data from multiple source cell lines with biological knowledge obtained from large language models. In addition, it includes a regulatory interaction extraction module that integrates gene expression profiles with semantic information. By transferring generalizable gene-gene regulatory patterns from source to target cell lines, TransGRN achieves state-of-the-art performance in both benchmark tests and few-shot GRN inference tasks.
- Top Cited PapersOpen Access
- 23 January 2024
- Published by Springer Nature in Nature Biotechnology
- Vol. 42 (10) , 1594-1605
Mosaic integration and knowledge transfer of single-cell multimodal data with MIDAS
Integrating single-cell datasets produced by multiple omics technologies is essential for defining cellular heterogeneity. Mosaic integration, in which different datasets share only some of the measured modalities, poses major challenges, particularly regarding modality alignment and batch effect removal. Here, we present a deep probabilistic framework for the mosaic integration and knowledge transfer (MIDAS) of single-cell multimodal data. MIDAS simultaneously achieves dimensionality reduction, imputation and batch correction of mosaic data by using self-supervised modality alignment and information-theoretic latent disentanglement. We demonstrate its superiority to 19 other methods and reliability by evaluating its performance in trimodal and mosaic integration tasks. We also constructed a single-cell trimodal atlas of human peripheral blood mononuclear cells and tailored transfer learning and reciprocal reference mapping schemes to enable flexible and accurate knowledge transfer from the atlas to new data. Applications in mosaic integration, pseudotime analysis and cross-tissue knowledge transfer on bone marrow mosaic datasets demonstrate the versatility and superiority of MIDAS. MIDAS is available at https://github.com/labomics/midas.
- 23 January 2024
- Published by Springer Nature in Nature Biotechnology
- Vol. 42 (10) , 1594-1605
Top Cited PapersOpen AccessMosaic integration and knowledge transfer of single-cell multimodal data with MIDAS
Integrating single-cell datasets produced by multiple omics technologies is essential for defining cellular heterogeneity. Mosaic integration, in which different datasets share only some of the measured modalities, poses major challenges, particularly regarding modality alignment and batch effect removal. Here, we present a deep probabilistic framework for the mosaic integration and knowledge transfer (MIDAS) of single-cell multimodal data. MIDAS simultaneously achieves dimensionality reduction, imputation and batch correction of mosaic data by using self-supervised modality alignment and information-theoretic latent disentanglement. We demonstrate its superiority to 19 other methods and reliability by evaluating its performance in trimodal and mosaic integration tasks. We also constructed a single-cell trimodal atlas of human peripheral blood mononuclear cells and tailored transfer learning and reciprocal reference mapping schemes to enable flexible and accurate knowledge transfer from the atlas to new data. Applications in mosaic integration, pseudotime analysis and cross-tissue knowledge transfer on bone marrow mosaic datasets demonstrate the versatility and superiority of MIDAS. MIDAS is available at https://github.com/labomics/midas.